Jessica Ann Zerillo, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medical Oncology | 8 | 2023 | 2265 | 0.960 |
Why?
|
Quality Indicators, Health Care | 3 | 2019 | 1831 | 0.910 |
Why?
|
Comprehensive Health Care | 1 | 2018 | 127 | 0.610 |
Why?
|
Quality Improvement | 5 | 2018 | 3749 | 0.540 |
Why?
|
Benchmarking | 1 | 2020 | 1042 | 0.460 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5319 | 0.360 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1439 | 0.330 |
Why?
|
Colorectal Neoplasms | 2 | 2019 | 6773 | 0.320 |
Why?
|
Medical Errors | 3 | 2023 | 1297 | 0.320 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2759 | 0.310 |
Why?
|
Neoplasms | 4 | 2020 | 21683 | 0.290 |
Why?
|
Antineoplastic Agents | 4 | 2021 | 13695 | 0.280 |
Why?
|
Administration, Oral | 4 | 2021 | 3913 | 0.270 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.240 |
Why?
|
Terminal Care | 1 | 2015 | 1694 | 0.230 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7913 | 0.200 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7659 | 0.190 |
Why?
|
Quality of Life | 2 | 2019 | 12804 | 0.190 |
Why?
|
Esophageal Neoplasms | 2 | 2021 | 1583 | 0.180 |
Why?
|
Anus Neoplasms | 1 | 2024 | 332 | 0.180 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 2019 | 48 | 0.180 |
Why?
|
Esophagectomy | 1 | 2021 | 447 | 0.150 |
Why?
|
Adenocarcinoma | 3 | 2021 | 6364 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11524 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4034 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7181 | 0.140 |
Why?
|
Central Venous Pressure | 1 | 2016 | 78 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5221 | 0.140 |
Why?
|
Patient Care Planning | 1 | 2020 | 921 | 0.120 |
Why?
|
Patient Care Team | 2 | 2017 | 2531 | 0.120 |
Why?
|
Delphi Technique | 1 | 2017 | 778 | 0.120 |
Why?
|
Data Mining | 1 | 2019 | 537 | 0.120 |
Why?
|
Lung Neoplasms | 2 | 2016 | 13102 | 0.120 |
Why?
|
Models, Organizational | 1 | 2017 | 574 | 0.110 |
Why?
|
Mutagenesis, Insertional | 1 | 2016 | 655 | 0.110 |
Why?
|
Documentation | 2 | 2019 | 871 | 0.110 |
Why?
|
Hepatectomy | 1 | 2016 | 550 | 0.110 |
Why?
|
Focus Groups | 1 | 2017 | 1321 | 0.110 |
Why?
|
Quality of Health Care | 2 | 2018 | 4371 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1587 | 0.100 |
Why?
|
Critical Pathways | 1 | 2015 | 476 | 0.100 |
Why?
|
Humans | 22 | 2024 | 744343 | 0.100 |
Why?
|
International Cooperation | 1 | 2017 | 1420 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2728 | 0.090 |
Why?
|
Program Evaluation | 1 | 2018 | 2488 | 0.090 |
Why?
|
Survivors | 1 | 2020 | 2291 | 0.090 |
Why?
|
Monitoring, Intraoperative | 1 | 2016 | 957 | 0.090 |
Why?
|
Quinazolines | 1 | 2016 | 1356 | 0.090 |
Why?
|
Leadership | 1 | 2018 | 1357 | 0.090 |
Why?
|
Risk Management | 2 | 2023 | 571 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 950 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1504 | 0.080 |
Why?
|
Aged | 9 | 2021 | 163280 | 0.080 |
Why?
|
Liver Diseases | 1 | 2016 | 1253 | 0.080 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2063 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2416 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2021 | 4468 | 0.070 |
Why?
|
Massachusetts | 2 | 2017 | 8663 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2278 | 0.060 |
Why?
|
Patient Compliance | 1 | 2015 | 2684 | 0.060 |
Why?
|
Clinical Competence | 1 | 2018 | 4687 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2024 | 77449 | 0.050 |
Why?
|
Palliative Care | 1 | 2017 | 3493 | 0.050 |
Why?
|
Research Design | 1 | 2018 | 5987 | 0.050 |
Why?
|
Male | 8 | 2021 | 350118 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4262 | 0.050 |
Why?
|
Hospitalization | 1 | 2018 | 10262 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5510 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5788 | 0.040 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.040 |
Why?
|
Health Records, Personal | 1 | 2019 | 124 | 0.040 |
Why?
|
Esophagogastric Junction | 1 | 2019 | 313 | 0.040 |
Why?
|
Female | 8 | 2021 | 380194 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5686 | 0.040 |
Why?
|
Games, Experimental | 1 | 2016 | 32 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2016 | 358 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 57776 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2017 | 352 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23338 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 63114 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2715 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2016 | 593 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2924 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 933 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7301 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 56430 | 0.020 |
Why?
|
Educational Measurement | 1 | 2016 | 1210 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3064 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2017 | 941 | 0.020 |
Why?
|
Teaching | 1 | 2016 | 1174 | 0.020 |
Why?
|
Risk Factors | 1 | 2015 | 72290 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6314 | 0.020 |
Why?
|
Adult | 3 | 2018 | 214055 | 0.020 |
Why?
|
United States | 1 | 2015 | 69872 | 0.020 |
Why?
|
Ultrasonography | 1 | 2019 | 5985 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 53288 | 0.020 |
Why?
|
Software | 1 | 2019 | 4443 | 0.020 |
Why?
|
Curriculum | 1 | 2016 | 3605 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11031 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29063 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39050 | 0.010 |
Why?
|